Total Versus Robotic Assisted Unicompartmental Knee Replacement
Launched by NHS LOTHIAN · Mar 11, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of knee surgery for patients with severe osteoarthritis (OA) in the inner part of the knee. One option is a traditional surgery called total knee arthroplasty (TKA), and the other is a newer, less invasive technique called robotic-assisted unicompartmental knee arthroplasty (UKA). The study aims to see which method helps patients recover better and whether there are differences in costs between the two types of surgery.
To participate in this trial, you need to be between 50 and 75 years old and have been recommended for knee surgery due to advanced OA. You should have a healthy anterior cruciate ligament and good quality cartilage on the outer side of your knee. If you have certain other health conditions or previous knee surgeries, you might not be eligible. If you join the study, you’ll be monitored during your recovery and asked to complete some questionnaires to help researchers understand the outcomes of each surgery. Your participation could contribute to important insights about knee surgeries and their effectiveness!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Listed for elective primary TKA for end stage medial compartment osteoarthritis
- • Intact anterior cruciate ligament
- • Full thickness and good quality lateral cartilage
- • Correctable intra-articular varus deformity and intact medial collateral ligament
- • American Society of Anesthesiologists (ASA) grades 1 and 2
- • Male or female, age 50 - 75 at the time of listing for surgery
- • Suitable candidate for a cruciate retaining TKA (Triathlon prosthesis) and a UKA
- Exclusion Criteria:
- • Varus deformity of \> 20 degrees
- • Fixed flexion of \>10 degrees
- • Patient is unable to comply with the study protocol (incl. refusal for CT scan) or functional assessments
- • Female participants who are pregnant, lactating or planning pregnancy during the course of the study
- • Requires patella resurfacing or lateral compartment has significant OA
- • Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or language reasons
- • Inflammatory disorder e.g. rheumatoid arthritis
- • Symptomatic foot, hip or spine pathology
- • Prior surgery (other than arthroscopy) or septic arthritis of the knee
- • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study,
About Nhs Lothian
NHS Lothian is a prominent healthcare organization based in Scotland, dedicated to delivering high-quality patient care and advancing medical research. As a key sponsor of clinical trials, NHS Lothian focuses on fostering innovative research initiatives that aim to improve health outcomes and inform clinical practice. With a commitment to ethical standards and patient safety, the organization collaborates with a network of healthcare professionals, academic institutions, and research partners to facilitate robust clinical studies across various therapeutic areas. Through its efforts, NHS Lothian plays a vital role in enhancing the evidence base for healthcare interventions and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, Lothian, United Kingdom
Patients applied
Trial Officials
Nicholas D Clement, MD, PhD
Principal Investigator
NHS Lothian
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials